| Ytd | -75.88% | |
| 1y | -91.43% |
| Open | 0.35 | Prev Close | 0.36 | Low | 0.33 | High | 0.37 | Mkt Cap | 378.81K |
| Vol | 220.26K | Avg Vol | 363.99K | EPS | -6.92 | P/E | -0.05 | Forward P/E | -0.01 |
| Beta | 1.84 | Short Ratio | 0.12 | Inst. Own | 3.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.96 | 200-d Avg | 2.09 | 1yr Est | 210.00 |
TIVC News
Ticker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod™ Tow
Tivic Health Systems, Inc. (NASDAQ: TIVC - Get Free Report) Director Sheryle Bolton acquired 10,000
SAN ANTONIO, April 15, 2026 /PRNewswire/ -- Tivic Health Systems, Inc. (Nasdaq: TIVC), a clinical-st
Tivic Health Systems (NASDAQ: TIVC - Get Free Report) and Omnicell (NASDAQ: OMCL - Get Free Report)
Tivic Health Systems (NASDAQ: TIVC) outlined its strategy to advance what it described as late-stage
Rennova Health (OTCMKTS:RNVA - Get Free Report) and Tivic Health Systems (NASDAQ: TIVC - Get Free Re
SAN ANTONIO, TX / ACCESS Newswire / March 31, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC), a cli
American Well (NYSE: AMWL - Get Free Report) and Tivic Health Systems (NASDAQ: TIVC - Get Free Repor
Presentation will Cover Recent Corporate Milestones Including Securing Agreement with NIAID SAN ANTO
Armed Forces Radiobiology Research Institute (AFRRI) Will Conduct the Gastrointestinal Acute Radiati
Tivic Health Systems, Inc. (TIVC) Q4 2025 Earnings Call Prepared Remarks Transcript
Completes Strategic Transformation into an Immunotherapy Company and Continues to Advance Entolimod
SAN ANTONIO, TX / ACCESS Newswire / March 24, 2026 / Tivic Health Systems (Nasdaq:TIVC) Dear Valued
Hims and Hers Health (NYSE: HIMS - Get Free Report) and Tivic Health Systems (NASDAQ: TIVC - Get Fre
SAN ANTONIO, TX / ACCESS Newswire / March 20, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC), a lat
SAN FRANCISCO, CA / ACCESS Newswire / March 4, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC) ("Tiv
Initial presentation on January 26, 2026 s howcased Entolimod's potential to mitigate and prevent bo
January 26 Presentation highlighted Entolimod's potential to mitigate and prevent both gastrointesti
CEO Presentation to Include Updates and Further Information on the Following Topics: Entolimod Cell
Tivic Health Systems, Inc. (NASDAQ: TIVC - Get Free Report) shares rose 0.8% during mid-day trading
On Tuesday, 647 companies set new 52-week lows.
During Thursday's session, 406 companies made new 52-week lows.
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q
During Wednesday's session, 212 companies made new 52-week lows.
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings f